Seoul, South Korea

Gwan Sun Lee

USPTO Granted Patents = 44 


 

Average Co-Inventor Count = 6.7

ph-index = 8

Forward Citations = 324(Granted Patents)


Location History:

  • Songpa-gu, KR (2010 - 2014)
  • Seoul, KR (2000 - 2021)

Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
IgG Fc Fragment
Polypeptide Complex
Recombinant Protein
Quinazoline Derivatives
Immunoglobulin Fragment
Pharmaceutical Composition
Cancer Cell Inhibition
Insulinotropic Peptide
Crystalline Compounds
Drug Carrier
Mass Production
Site-Specific Conjugates
44 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gwan Sun Lee: Pioneering Drug Delivery Solutions

Introduction: Gwan Sun Lee, a prolific inventor based in Seoul, South Korea, has made significant strides in the field of biotechnology, particularly in drug delivery systems. With a remarkable portfolio of 44 patents, Lee is recognized for his inventive solutions that enhance the effectiveness of therapeutics.

Latest Patents: Among Lee's latest innovations are two patents focusing on improving drug delivery mechanisms. The first patent, titled "IgG Fc fragment for a drug carrier and method for the preparation thereof," introduces an IgG Fc fragment that serves as an effective drug carrier. It outlines a recombinant vector expressing this fragment, revealing that its conjugation to specific drugs can significantly extend their in vivo duration of action while minimizing any reduction in activity.

His second patent, titled "Polypeptide complex comprising non-peptidyl polymer having three functional ends," describes a complex that features a physiologically active polypeptide, a dimeric protein, and a unique non-peptidyl polymer with three functional ends. This innovative protein complex not only enhances the stability and bioactivity of active polypeptides but also improves their serum half-life, making it suitable for sustained release formulations. Moreover, the use of raw materials without significant loss boosts production yield, and the process allows for easy purification.

Career Highlights: Gwan Sun Lee has contributed to the growth of the biotechnology sector through his work with leading companies, namely Hanmi Science Co., Ltd. and Hanmi Pharm. Co., Ltd. His experience across these firms has fueled his innovative pursuits, leading to significant advancements in drug formulation and delivery.

Collaborations: Throughout his career, Lee has collaborated with notable colleagues such as Se Chang Kwon and Sung Youb Jung. These partnerships have not only enriched the development of his inventions but have also stimulated innovation within the biotechnology community.

Conclusion: Gwan Sun Lee's dedication to advancing drug delivery technologies exemplifies the impact of innovative thinking in biotech. With his substantial number of patents and groundbreaking approaches, he continues to inspire future innovations in the field, paving the way for more effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…